Stopping TKI therapy can be safe, study suggestsJune 23, 2016Leukemia, Myelodysplasia, TransplantationCML
Most CML patients who stop nilotinib stay in remissionJune 13, 2016Leukemia, Myelodysplasia, TransplantationCML
High costs limit CML patients’ access to TKIsMarch 29, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Starting all CML patients on imatinib could cut costs, team saysMarch 16, 2016Leukemia, Myelodysplasia, TransplantationCML
Germline mutations linked to hematologic malignanciesMarch 10, 2016AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLMyelodysplastic SyndromeHodgkin LymphomaCML
Pinpointing the cells that cause CML relapseFebruary 18, 2016Leukemia, Myelodysplasia, TransplantationCML
New assay detects persistent CML better, team saysFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationCML
Generic imatinib launched with savings programFebruary 4, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLMyelodysplastic Syndrome
Potential new alternative in CML when TKI therapy failsDecember 21, 2015Leukemia, Myelodysplasia, TransplantationCML
Osteoarticular pain affects CML patients stopping TKIDecember 18, 2015Leukemia, Myelodysplasia, TransplantationCML
FDA approves generic imatinibDecember 6, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
